Clobetasol

• 

  Subject Areas on Research

  • A controlled trial of clobetasol propionate ointment 0.05% in the treatment of experimentally induced Rhus dermatitis. 
  • A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis. 
  • Adrenal suppression following low-dose topical clobetasol propionate. 
  • Adrenal suppression following low-dose topical clobetasol propionate. 
  • Bone-anchored hearing aid abutment skin overgrowth reduction with clobetasol. 
  • Clobetasol propionate versus fluocinonide creams in psoriasis and eczema. 
  • Early aggressive treatment of lichen sclerosus may prevent disease progression. 
  • Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate. 
  • Identification of select glucocorticoids as Smoothened agonists: potential utility for regenerative medicine. 
  • Intraurethral Steroids are a Safe and Effective Treatment for Stricture Disease in Patients with Biopsy Proven Lichen Sclerosus. 
  • Medical Management of Penile and Urethral Lichen Sclerosus with Topical Clobetasol Improves Long-Term Voiding Symptoms and Quality of Life. 
  • Pityriasis rubra pilaris and severe hypereosinophilia. 
  • Topical clobetasol-17-propionate: review of its clinical efficacy and safety.